tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Augmedix upgraded to Outperform from In Line at Evercore ISI

Evercore ISI upgraded Augmedix (AUGX) to Outperform from In Line with a $5 price target. The firm sees Augmedix continuing with its strong momentum, further bolstered by its recent go-to-market partnership with SADA, and believes progression with HCA Healthcare (HCA) and related announcements will be a short-term catalyst.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1